Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells

OBJECTIVE: Hepatocellular carcinoma (HCC) is the most common liver malignancy. Sorafenib is the first-line systemic treatment for advanced HCCs. However, due to safety concerns, researchers are now looking for ways to boost the efficacy of the medication. One approach for reducing toxicity is combin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian Pac J Cancer Prev
Main Authors: Seyhoun, Iman, Hajighasemlou, Saieh, Ai, Jafar, Hosseinzadeh, Faezeh, Mirmoghtadaei, Milad, Seyhoun, Seyed Moein, Parseh, Benyamin, Abdolahi, Shahrokh, Ghazvinian, Zeinab, Shadnoush, Mahdi, Verdi, Javad
Formato: Artigo
Idioma:Inglês
Publicado em: West Asia Organization for Cancer Prevention 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6485565/
https://ncbi.nlm.nih.gov/pubmed/30678447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.1.263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados